Physician profile
Sonia Wengerhoff
NPI 1124260625
$404.56
in general payments reported to CMS, 2019-2025
11 companies · $90.91 in 2025
The $90.91 reported for 2025 was less than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.50 · 2020: $31.76 · 2021: $92.72 · 2022: $54.34 · 2023: $22.47 · 2024: $31.86 · 2025: $90.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $145.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $125.57 | 2019-2025 | Vaxneuvance, Rotateq, Vaxelis |
| Kaleo, INC. | $54.92 | 2019-2024 | Auvi-Q |
| Pfizer INC. | $45.26 | 2019-2022 | |
| Sobi, INC | $43.25 | 2021 | |
| Corium, LLC | $28.11 | 2025 | Azstarys |
| Sanofi Pasteur INC. | $22.17 | 2021 | |
| Glaxosmithkline, LLC. | $21.73 | 2019 | |
| Hologic Sales and Service, LLC | $19.35 | 2025 | Aptima |
| Alk-Abello, INC | $15.72 | 2021 | |
| Noven Therapeutics, LLC | $14.57 | 2024 | Xelstrym |
| Shire North American Group INC | $13.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonia Wengerhoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.